Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Inorganic Scintillators
... CAGR of 5.5% over the analysis period 2024-2030. Sodium Iodide (NaI) Material, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$200.2 Million by the end of ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Service, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Cervical Cancer Diagnostic Testing
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Pap Smear Testing, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$5.3 Billion by ... Read More
-
Coagulation Testing
... CAGR of 4.8% over the analysis period 2024-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.7 Billion by the end of the ... Read More
-
Contrast Injectors
... CAGR of 4.5% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$470.8 Million by the end of the analysis period. ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Critical Care Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the ... Read More
-
Dental Digital X-ray
... at a CAGR of 5.9% over the analysis period 2024-2030. Extraoral X-ray, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Dental Radiology Equipment
... at a CAGR of 4.1% over the analysis period 2024-2030. Extraoral X-Ray Systems, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$6.3 Billion by the end ... Read More
-
Medical Radiation Shielding
... at a CAGR of 5.0% over the analysis period 2024-2030. MRI Shielding Products, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$672.8 Million by the end ... Read More
-
Mycoplasma Testing
... CAGR of 8.6% over the analysis period 2024-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$940.8 Million by the end of ... Read More
-
Non-Invasive Fat Reduction Technologies
... 2030, growing at a CAGR of 15.8% over the analysis period 2024-2030. Cryolipolysis, one of the segments analyzed in the report, is expected to record a 16.6% CAGR and reach US$2.5 Billion by the end ... Read More
-
Nuclear Medicine Radioisotope
... at a CAGR of 7.8% over the analysis period 2024-2030. Technetium-99m (Tc-99m), one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$11.7 Billion by the end of ... Read More
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Clostridium Diagnostics
... CAGR of 14.2% over the analysis period 2024-2030. Immunoassays Technology, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$9.1 Billion by the end of the analysis ... Read More
-
Coagulation / Hemostasis Analyzers
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$3.8 Billion by ... Read More
-
E. Coli Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Environmental Testing, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.0 Billion by the end of ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
-
Industrial Microbiology
... CAGR of 4.6% over the analysis period 2024-2030. Pharmaceuticals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Predictive and Presymptomatic Testing
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 12.7% CAGR The Predictive and Presymptomatic Testing market ... Read More
-
Protein Binding Assays
... at a CAGR of 9.4% over the analysis period 2024-2030. Equilibrium Dialysis, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$342.2 Million by the end of ... Read More
Research Assistance
